Publication | Closed Access
Catch‐Up Growth During Tocilizumab Therapy for Systemic Juvenile Idiopathic Arthritis: Results From a Phase III Trial
75
Citations
27
References
2014
Year
Our findings indicate that during treatment with tocilizumab, patients with systemic JIA experience significant catch-up growth, normalization of IGF-1 levels, and bone balance improvement favoring bone formation.
| Year | Citations | |
|---|---|---|
Page 1
Page 1